Editorial
BibTex RIS Cite

The potential of artificial intelligence and machine learning algorithms in the field of cardiovascular diseases

Year 2024, Volume: 8 Issue: 2, 91 - 92, 30.08.2024
https://doi.org/10.30565/medalanya.1537200

Abstract

Artificial intelligence (AI) and machine learning (ML) is a form of intelligence that has a wide-reaching impact on various aspects of contemporary life, including the field of medicine. Artificial intelligence tools and technology are utilized for the early identification and diagnosis of severe or intricate heart conditions. The potential of artificial intelligence (AI) in cardiovascular medicine is significant. However, the major challenges hindering the development of AI applications in this field include the scarcity of diverse data and limited availability of huge datasets. These revolutionary digital technologies will play a significant role in shaping the future of cardiology.

References

  • 1. Ledziński Ł, Grześk G. Artificial Intelligence Technologies in Cardiology. J Cardiovasc Dev Dis. 2023;10(5):202. doi: 10.3390/jcdd10050202
  • 2. Harmon DM, Sehrawat O, Maanja M, Wight J, Noseworthy PA. Artificial Intelligence for the Detection and Treatment of Atrial Fibrillation. Arrhythm Electrophysiol Rev. 2023;12:e12. doi: 10.15420/aer.2022.31
  • 3. Yoon M, Park JJ, Hur T, Hua CH, Hussain M, Lee S, et al. Application and Potential of Artificial Intelligence in Heart Failure: Past, Present, and Future. Int J Heart Fail. 2023; 6(1):11-19. doi: 10.36628/ijhf.2023.0050
  • 4. Kwon JM, Jo YY, Lee SY, Kang S, Lim SY, Lee MS, et al. Artificial Intelligence-Enhanced Smartwatch ECG for Heart Failure-Reduced Ejection Fraction Detection by Generating 12-Lead ECG. Diagnostics (Basel). 2022;12(3):654. doi: 10.3390/diagnostics12030654
  • 5. Hayıroğlu Mİ, Altay S. The Role of Artificial Intelligence in Coronary Artery Disease and Atrial Fibrillation. Balkan Med J. 2023;40(3):151-152. doi: 10.4274/balkanmedj.galenos.2023.06042023
  • 6. Kampaktsis PN, Emfietzoglou M, Al Shehhi A, Fasoula NA, Bakogiannis C, Mouselimis D, et al. Artificial intelligence in atherosclerotic disease: Applications and trends. Front Cardiovasc Med. 2023;9:949454. doi: 10.3389/fcvm.2022.949454

Kardiyovasküler hastalıklar alanında yapay zeka ve makine öğrenimi algoritmalarının potansiyeli

Year 2024, Volume: 8 Issue: 2, 91 - 92, 30.08.2024
https://doi.org/10.30565/medalanya.1537200

Abstract

Yapay zeka (AI) ve makine öğrenimi (ML), tıp da dahil olmak üzere modern yaşamın neredeyse her alanına dokunan bir zekadır. Yapay zeka araçları ve teknolojileri, ciddi veya karmaşık kalp sorunlarının erken risk tahmini ve teşhisine uygulanmaktadır. Kardiyovasküler tıpta yapay zekanın potansiyeli büyüktür, ancak sınırlı veri çeşitliliği ve birçok büyük veri tabanına erişim eksikliği, yapay zeka uygulamalarının geliştirilmesinin önündeki en büyük engeller arasındadır. Kardiyolojinin geleceği büyük ölçüde bu yenilikçi dijital teknolojilere dayanacaktır.

References

  • 1. Ledziński Ł, Grześk G. Artificial Intelligence Technologies in Cardiology. J Cardiovasc Dev Dis. 2023;10(5):202. doi: 10.3390/jcdd10050202
  • 2. Harmon DM, Sehrawat O, Maanja M, Wight J, Noseworthy PA. Artificial Intelligence for the Detection and Treatment of Atrial Fibrillation. Arrhythm Electrophysiol Rev. 2023;12:e12. doi: 10.15420/aer.2022.31
  • 3. Yoon M, Park JJ, Hur T, Hua CH, Hussain M, Lee S, et al. Application and Potential of Artificial Intelligence in Heart Failure: Past, Present, and Future. Int J Heart Fail. 2023; 6(1):11-19. doi: 10.36628/ijhf.2023.0050
  • 4. Kwon JM, Jo YY, Lee SY, Kang S, Lim SY, Lee MS, et al. Artificial Intelligence-Enhanced Smartwatch ECG for Heart Failure-Reduced Ejection Fraction Detection by Generating 12-Lead ECG. Diagnostics (Basel). 2022;12(3):654. doi: 10.3390/diagnostics12030654
  • 5. Hayıroğlu Mİ, Altay S. The Role of Artificial Intelligence in Coronary Artery Disease and Atrial Fibrillation. Balkan Med J. 2023;40(3):151-152. doi: 10.4274/balkanmedj.galenos.2023.06042023
  • 6. Kampaktsis PN, Emfietzoglou M, Al Shehhi A, Fasoula NA, Bakogiannis C, Mouselimis D, et al. Artificial intelligence in atherosclerotic disease: Applications and trends. Front Cardiovasc Med. 2023;9:949454. doi: 10.3389/fcvm.2022.949454
There are 6 citations in total.

Details

Primary Language English
Subjects Clinical Sciences (Other)
Journal Section Editorial
Authors

Can Öncel 0000-0001-5422-6847

Ahmet Aslan 0000-0001-5797-1287

Publication Date August 30, 2024
Submission Date August 22, 2024
Acceptance Date August 23, 2024
Published in Issue Year 2024 Volume: 8 Issue: 2

Cite

Vancouver Öncel C, Aslan A. The potential of artificial intelligence and machine learning algorithms in the field of cardiovascular diseases. Acta Med. Alanya. 2024;8(2):91-2.

9705

This Journal is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.